β-Amyloid(40-1)

CAS No. 144409-99-4

β-Amyloid(40-1)( ——— )

Catalog No. M40686 CAS No. 144409-99-4

β-Amyloid (40-1) is a biological active peptide. (non-toxic reverse fragment Aβ(40–1)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    β-Amyloid(40-1)
  • Note
    Research use only, not for human use.
  • Brief Description
    β-Amyloid (40-1) is a biological active peptide. (non-toxic reverse fragment Aβ(40–1)
  • Description
    β-Amyloid (40-1) is a biological active peptide. (non-toxic reverse fragment Aβ(40–1)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    144409-99-4
  • Formula Weight
    4329.9
  • Molecular Formula
    C194H295N53O58S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • TLC2976-0103

    ROCK1-IN-1 is an inhibitor of ROCK1 with a K i value of 540 nM. ROCK1-IN-1 can be used in the research of hypertension, glaucoma and erectile dysfunction .

  • 2-Methylsuccinic aci...

    Methylsuccinic acid is a normal metabolite found in human fluids. Increased urinary levels of Methylsuccinic acid (together with ethylmalonic acid) are the main biochemical measurable features in ethylmalonic encephalopathy a rare metabolic disorder with an autosomal recessive mode of inheritance that is clinically characterized by neuromotor delay hyperlactic acidemia recurrent petechiae orthostatic acrocyanosis and chronic diarrhea.

  • PLpro/RBD-IN-1

    PLpro/RBD-IN-1 is a dual inhibitor of SARS-CoV-2 PLpro and the spiny protein RBD, with anti-novel coronavirus activity, and is seen for the study of viral infections.